Research
Making a difference for our future through expanded research efforts.
New Research
Attracting outstanding scientists to contribute to GW cancer research efforts is a primary goal of the Katzen Cancer Research Center. With the new, state-of-the-art clinical facilities, the Center is poised to considerably expand its research efforts by adding scientists, clinicians and support staff dedicated to the discovery of new cancer therapies.
Current Research
Through its Medical Center, GW already is involved in several clinical trial studies designed to advance scientific knowledge for cancer care. Examples of current research efforts include the following:
-
The ASSURE Study
Researchers are testing two drugs (Sorafinib and Sunitinib) to prevent recurrence in kidney cancer patients. There is currently no treatment available for kidney cancer patients after surgery. They are comparing the disease-free survival of patients with kidney cancer, treated with one of these two drugs after surgery, versus patients treated with a placebo after surgery. -
The Amgen 20060197 Study
This study uses the drug Romiplostim as a treatment for low platelet count in patients with myelodysplastic syndrome. This study focuses on the long-term safety and efficacy of the drug. -
Adjuvant Treatment for Breast Cancer Patients with High-risk for Recurrence
This study seeks to determine if adding the drug Avastin to the current standard chemotherapy medications will reduce the risk of recurrence, compared to standard chemotherapy alone.